Table 2.
Proportion of patients in the primary and secondary prevention groups taking statins and undergoing lipid testing, by age group
| AGE GROUP | PRIMARY PREVENTION GROUP | SECONDARY PREVENTION GROUP | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| TOTAL NO. OF PATIENTS | NO. TAKING STATINS (%) | NO. UNDERGOING LIPID TESTING (%) | TOTAL NO. OF PATIENTS | NO. TAKING STATINS (%) | NO. UNDERGOING LIPID TESTING (%) | |
| 20–24 | 11 654 | 0 (0) | 903 (8) | 25 | 0 (0) | 2 (8) |
| 25–29 | 11 530 | 4 (0) | 1165 (10) | 33 | 1 (3) | 4 (12) |
| 30–34 | 11 271 | 17 (0) | 1399 (12) | 54 | 2 (4) | 21 (39) |
| 35–39 | 11 341 | 45 (0) | 1859 (16) | 47 | 2 (4) | 3 (6.4) |
| 40–44 | 11 813 | 94 (1) | 2519 (21) | 111 | 11 (10) | 49 (44) |
| 45–49 | 12 420 | 200 (2) | 3135 (25) | 195 | 40 (21) | 97 (50) |
| 50–54 | 13 792 | 479 (4) | 4315 (31) | 398 | 90 (23) | 197 (50) |
| 55–59 | 12 961 | 752 (6) | 4358 (34) | 627 | 193 (31) | 316 (50) |
| 60–64 | 11 465 | 1042 (9) | 3897 (34) | 959 | 329 (34) | 475 (50) |
| 65–69 | 9510 | 1078 (11) | 3246 (34) | 1177 | 399 (34) | 569 (48) |
| 70–74 | 6454 | 870 (13) | 2266 (35) | 1237 | 474 (38) | 585 (47) |
| 75–79 | 4612 | 590 (13) | 1509 (33) | 1264 | 464 (37) | 608 (48) |
| 80–84 | 3767 | 408 (11) | 1046 (28) | 1359 | 440 (32) | 610 (45) |
| 85–89 | 3024 | 261 (9) | 632 (21) | 1279 | 325 (25) | 468 (37) |
| 90–94 | 2157 | 105 (5) | 255 (12) | 1036 | 188 (18) | 288 (28) |
| 95–99 | 1254 | 10 (1) | 86 (7) | 436 | 55 (13) | 95 (22) |